24,502 Shares in Baxter International Inc. $BAX Bought by One Way Holdings LLC

One Way Holdings LLC bought a new position in Baxter International Inc. (NYSE:BAX) in the 3rd quarter, HoldingsChannel.com reports. The fund bought 24,502 shares of the medical instruments supplier’s stock, valued at approximately $588,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. CX Institutional raised its stake in shares of Baxter International by 2.3% during the third quarter. CX Institutional now owns 19,858 shares of the medical instruments supplier’s stock worth $477,000 after acquiring an additional 448 shares in the last quarter. Baird Financial Group Inc. lifted its holdings in shares of Baxter International by 1.1% in the 2nd quarter. Baird Financial Group Inc. now owns 44,722 shares of the medical instruments supplier’s stock worth $953,000 after acquiring an additional 476 shares during the last quarter. North Dakota State Investment Board lifted its holdings in shares of Baxter International by 3.3% in the 3rd quarter. North Dakota State Investment Board now owns 15,735 shares of the medical instruments supplier’s stock worth $378,000 after acquiring an additional 500 shares during the last quarter. CWA Asset Management Group LLC boosted its stake in shares of Baxter International by 5.0% in the 3rd quarter. CWA Asset Management Group LLC now owns 12,617 shares of the medical instruments supplier’s stock valued at $303,000 after purchasing an additional 599 shares in the last quarter. Finally, Empirical Finance LLC boosted its stake in shares of Baxter International by 3.5% in the 2nd quarter. Empirical Finance LLC now owns 18,170 shares of the medical instruments supplier’s stock valued at $387,000 after purchasing an additional 608 shares in the last quarter. 90.19% of the stock is currently owned by institutional investors.

Baxter International Price Performance

Shares of Baxter International stock opened at $24.15 on Tuesday. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.95 and a quick ratio of 1.32. The business’s 50 day simple moving average is $24.54 and its two-hundred day simple moving average is $21.39. The stock has a market capitalization of $12.49 billion, a P/E ratio of -17.13, a price-to-earnings-growth ratio of 3.85 and a beta of 0.65. Baxter International Inc. has a one year low of $15.73 and a one year high of $30.00.

Baxter International (NYSE:BAX) last announced its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.06. The firm had revenue of $2.98 billion during the quarter, compared to the consensus estimate of $2.91 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%. The business’s revenue was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.69 earnings per share. Analysts forecast that Baxter International Inc. will post 2.10 EPS for the current year.

Baxter International Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, November 27th will be paid a $0.01 dividend. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, November 27th. Baxter International’s payout ratio is presently -2.84%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Wall Street Zen raised shares of Baxter International from a “hold” rating to a “buy” rating in a report on Saturday. JPMorgan Chase & Co. lowered their price target on shares of Baxter International from $26.00 to $25.00 and set a “neutral” rating for the company in a research note on Friday. UBS Group boosted their price target on shares of Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a research note on Tuesday, July 28th. Wells Fargo & Company upped their price target on shares of Baxter International from $23.00 to $25.00 and gave the company an “equal weight” rating in a research report on Friday. Finally, Wolfe Research assumed coverage on Baxter International in a research note on Tuesday, October 20th. They set a “peer perform” rating on the stock. One investment analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average target price of $23.00.

About Baxter International

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.